A Single-Gene Cause in 29.5% of Cases of Steroid-Resistant Nephrotic Syndrome
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Steroid-resistant nephrotic syndrome (SRNS) is the second most frequent cause of ESRD in the first two decades of life. Effective treatment is lacking. First insights into disease mechanisms came from identification of single-gene causes of SRNS. However, the frequency of single-gene causation and its age distribution in large cohorts are unknown. We performed exon sequencing of NPHS2 and WT1 for 1783 unrelated, international families with SRNS. We then examined all patients by microfluidic multiplex PCR and next-generation sequencing for all 27 genes known to cause SRNS if mutated. We detected a single-gene cause in 29.5% (526 of 1783) of families with SRNS that manifested before 25 years of age. The fraction of families in whom a single-gene cause was identified inversely correlated with age of onset. Within clinically relevant age groups, the fraction of families with detection of the single-gene cause was as follows: onset in the first 3 months of life (69.4%), between 4 and 12 months old (49.7%), between 1 and 6 years old (25.3%), between 7 and 12 years old (17.8%), and between 13 and 18 years old (10.8%). For PLCE1, specific mutations correlated with age of onset. Notably, 1% of individuals carried mutations in genes that function within the coenzyme Q10 biosynthesis pathway, suggesting that SRNS may be treatable in these individuals. Our study results should facilitate molecular genetic diagnostics of SRNS, etiologic classification for therapeutic studies, generation of genotype-phenotype correlations, and the identification of individuals in whom a targeted treatment for SRNS may be available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“among these were many gene products currently known to be associated with hereditary nephrotic syndrome (Sadowski et al., 2015).”
From A Multi-layered Quantitative In Vivo Expression Atlas of the Podocyte Unravels Kidney Disease Candidate Genes (2018) · cites this paper as Sadowski et al., 2015
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boute, N., Gribouval, O., Roselli, S., Benessy, F., Lee, H., Fuchshuber, A., Dahan, K., Gubler, M.-C., Niaudet, P., & Antignac, C. (2000) · Nature Genetics · doi:10.1038/74166 · Cited by 1,444
The spectrum of podocytopathies: A unifying view of glomerular diseases
Wiggins, R.-C. (2007) · Kidney International · doi:10.1038/sj.ki.5002222 · Cited by 757
Hinkes, B., Wiggins, R. C., Gbadegesin, R., Vlangos, C. N., Seelow, D., Nürnberg, G., Garg, P., Verma, R., Chaib, H., Hoskins, B. E., et al. (2006) · Nature Genetics · doi:10.1038/ng1918 · Cited by 569
Self-citationSmith, J. M., Stablein, D. M., Munoz, R., Hebert, D., & McDonald, R. A. (2007) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2007.00704.x · Cited by 479
Hinkes, B. G., Mucha, B., Vlangos, C. N., Gbadegesin, R., Liu, J., Hasselbacher, K., Hangan, D., Ozaltin, F., Zenker, M., Hildebrandt, F., et al. (2007) · Pediatrics · doi:10.1542/peds.2006-2164 · Cited by 444
Self-citationRuf, R. G., Lichtenberger, A., Karle, S. M., Haas, J. P., Anacleto, F. E., Schultheiss, M., Zalewski, I., Imm, A., Ruf, E.-M., Mucha, B., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000113552.59155.72 · Cited by 417
Self-citationCOQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness
Heeringa, S. F., Chernin, G., Chaki, M., Zhou, W., Sloan, A. J., Ji, Z., Xie, L. X., Salviati, L., Hurd, T. W., Vega-Warner, V., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45693 · Cited by 398
Self-citationWeber, S., Gribouval, O., Esquivel, E. L., Morinière, V., Tête, M.-J., Legendre, C., Niaudet, P., & Antignac, C. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00776.x · Cited by 375
ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption
Ashraf, S., Gee, H. Y., Woerner, S., Xie, L. X., Vega-Warner, V., Lovric, S., Fang, H., Song, X., Cattran, D. C., Avila-Casado, C., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69000 · Cited by 341
Self-citationGetting a foothold in nephrotic syndrome
Somlo, S., & Mundel, P. (2000) · Nature Genetics · doi:10.1038/74139 · Cited by 271
Cited by
Items 301–400 of 651
Unveiling the genetic architecture of kidney disease
Devuyst, O. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.177 · Cited by 11
Demir, E., & Çalışkan, Y. (2019) · Pediatric Nephrology · doi:10.1007/s00467-019-04282-y · Cited by 12
Berardo, A., & Quinzii, C. M. (2020) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2020.02 · Cited by 12
“Four phenotypic groups can be defined: (1) SRNS, isolated or with neurological involvement, associated with defects in PDSS2, COQ2, COQ6, or COQ8B (the latter with later age-at-onset); (2) encephalomyopathy, hypertrophic/dilated cardiomyopathy, lactic acidosis, and tubulopathy with defects in PDSS2, COQ2, COQ7, or COQ…”
BackgroundInfluentialRecessive Mutations in SYNPO2 as a Candidate of Monogenic Nephrotic Syndrome
Mao, Y., Schneider, R., van der Ven, P. F. M., Aßent, M., Lohanadan, K., Klämbt, V., Buerger, F., Kitzler, T. M., Deutsch, K., Nakayama, M., et al. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.10.040 · Cited by 11
Self-citationCase Report: CMV-Associated Congenital Nephrotic Syndrome
Jacob, A. M., Habeeb, S. M., Herlitz, L., Šimková, E., Shekhy, J. F., Taylor, A., Abuhammour, W., Tayoun, A. N. A., & Bitzan, M. M. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.580178 · Cited by 11
Najafi, M., Riedhammer, K. M., Rad, A., Torbati, P. N., Berutti, R., Schüle, I., Schroda, S., Meitinger, T., Ćomić, J., Sadeghi‐Bojd, S., et al. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.974840 · Cited by 11
Nephrotic Syndrome: Updates and Approaches to Treatment
Rheault, M. N. (2016) · Current Treatment Options in Pediatrics · doi:10.1007/s40746-016-0044-x · Cited by 14
“Children with steroid-resistant disease may have an underlying genetic cause for NS, and providers should consider genetic testing in this population, depending on the age of the child [2].”
BackgroundKino, J., Tsukaguchi, H., Kimata, T., Nguyen, H. T., Nakano, Y., Miyake, N., Matsumoto, N., & Kaneko, K. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0632-4 · Cited by 11
Individualizing Treatment of Steroid-Resistant Nephrotic Syndrome
Bagga, A., & Sinha, A. P. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08080520 · Cited by 11
Genetic Causes of Nephrotic Syndrome and Focal and Segmental Glomerulosclerosis
Çaparali, E. B., Gregorio, V. D., & Barua, M. (2024) · Advances in Kidney Disease and Health · doi:10.1053/j.akdh.2024.04.001 · Cited by 13
Clinical utility of genetic testing in Indian children with kidney diseases
Saha, A., Kapadia, S. F., Vala, K. B., & Patel, H. V. (2023) · BMC Nephrology · doi:10.1186/s12882-023-03240-z · Cited by 10
Büscher, A. K., Celebi, N., Hoyer, P. F., Klein, H., Weber, S., & Hoefele, J. (2017) · Pediatric Nephrology · doi:10.1007/s00467-017-3811-4 · Cited by 12
Mulukala, S. K. N., Kar, P. P., Vadrevu, R., & Pasupulati, A. K. (2019) · Molecular Simulation · doi:10.1080/08927022.2019.1570508 · Cited by 9
“The idiopathic NS is classified into steroid-sensitive (SSNS) and steroid-resistant (SRNS), depending on their response to corticosteroid therapy.”
BackgroundInfluentialThe Use of Genomics to Drive Kidney Disease Drug Discovery and Development
Reilly, D. F., & Breyer, M. D. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11070919 · Cited by 10
Integration of genetic and histopathology data in interpretation of kidney disease
Murray, S. L., Fennelly, N. K., Doyle, B. J., Lynch, S. A., & Conlon, P. J. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa176 · Cited by 11
Hashmi, J. A., Safar, R. A., Afzal, S., Albalawi, A. M., Abdu‐Samad, F., Iqbal, Z., & Basit, S. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9528 · Cited by 10
“Recessive mutations in this gene cause early-onset nephrotic syndrome (13,27).”
Zhang, L., Zhao, F., Ding, G., Chen, Y., Zhao, S., Chen, Q., Sha, Y., Che, R., Huang, S., Zheng, B., et al. (2023) · Kidney Diseases · doi:10.1159/000534853 · Cited by 10
Generation of Monogenic Candidate Genes for Human Nephrotic Syndrome Using 3 Independent Approaches
Klämbt, V., Mao, Y., Schneider, R., Buerger, F., Shamseldin, H. E., Onuchic-Whitford, A. C., Deutsch, K., Kitzler, T. M., Nakayama, M., Majmundar, A. J., et al. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.11.013 · Cited by 10
“5% of cases.(9,10,12,13) Cases unsolved for known NS genes were then subjected to unbiased WES analysis.”
BackgroundSelf-citationThomas, M. M., Ahmed, H. M., El‐Dessouky, S. H., Ramadan, A., Botrous, O. E., & Abdel‐Hamid, M. S. (2022) · Molecular Genetics and Genomics · doi:10.1007/s00438-022-01877-3 · Cited by 10
Lim, C. C., Lim, R. S., Choo, J. C. J., Leow, E. H., Chan, G. C., Zhang, Y., Ng, J. L., Chin, H.-L. L., Tan, E. S., Goh, J., et al. (2024) · American Journal of Nephrology · doi:10.1159/000542942 · Cited by 12
“Moreover, 20 – 30% of children with steroid-resistant nephrotic syndrome and 10% of adults with FSGS have genetic causes that generally do not respond to immunosuppression [14 – 18].”
van der Wolde, J. W., Haruhara, K., Puelles, V. G., Nikolic‐Paterson, D. J., Bertram, J. F., & Cullen‐McEwen, L. A. (2022) · Cell and Tissue Research · doi:10.1007/s00441-022-03611-2 · Cited by 12
Trautmann, A., Seide, S., Lipska-Ziętkiewicz, B. S., Özaltın, F., Szczepańska, M., Azocar, M. A., Jankauskienė, A., Zurowska, A. M., Çalışkan, S., Saeed, B., et al. (2022) · Pediatric Nephrology · doi:10.1007/s00467-022-05762-4 · Cited by 9
Chen, Y., Zhang, Y., Huang, J., Zeng, Y., Qian, Y., Chen, J., Chen, G., Xia, G., Wang, C., Ai, F., et al. (2023) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.2163 · Cited by 9
“These results were in accordance with previous studies showing that the recessive gene NPHS1 led to onset of steroid- resistant nephrotic syndrome (SRNS) in early childhood and NPHS1 variant occurred in congenital NS only (Hinkes et al., 2007; Sadowski et al., 2015).”
Govender, M. A., Fabian, J., Gottlich, E., Levy, C. S., Moonsamy, G., Maher, H., Winkler, C. A., & Ramsay, M. (2019) · Communications Biology · doi:10.1038/s42003-019-0658-1 · Cited by 9
Zhu, Y., & Xu, G. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s498457 · Cited by 8
Soliman, N. A., Elmonem, M. A., El-Sayed, A. F., Ramadan, E. S., Badr, A., Atia, F. M., Helmy, R., Amer, M. O., El-Raouf, A. A., Elgarhy, F. M., et al. (2025) · Human Genetics · doi:10.1007/s00439-025-02752-y · Cited by 8
Self-citationDefining diagnostic trajectories in patients with podocytopathies
Cirillo, L., Lugli, G., Raglianti, V., Ravaglia, F., Buti, E., Landini, S., & Becherucci, F. (2022) · Clinical Kidney Journal · doi:10.1093/ckj/sfac123 · Cited by 10
“Overall, monogenic podocytopathies account for ∼30% of cases undergoing genetic testing [95, 100].”
Han, Y., Sha, H., Yang, Y., Yu, Z., Zhou, L., Wang, Y., Yang, F., Qiu, L., Zhang, Y., & Zhou, J. (2024) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-024-01656-3 · Cited by 8
“Recent studies have identified an increasing number of genes associated with the development of SRNS, totally accounting for 29.5% of SRNS as reported by Hildebrandt [6].”
ResultInfluentialIchikawa, Y., Sakakibara, N., Nagano, C., Inoki, Y., Tanaka, Y., Ueda, C., Kitakado, H., Kondo, A., Ishimori, S., Horinouchi, T., et al. (2024) · Pediatric Nephrology · doi:10.1007/s00467-024-06468-5 · Cited by 8
“In a previous worldwide cohort, the proportion of families with detected monogenic cause at 1, 2, and 3 years of age remained almost unchanged at approximately 25% [12], while in the present study, the proportion according to age at onset was higher at 3 years of age.”
BackgroundPotential and pitfalls in the genetic diagnosis of kidney diseases
Kesselheim, A., Ashton, E., & Böckenhauer, D. (2017) · Clinical Kidney Journal · doi:10.1093/ckj/sfx075 · Cited by 9
“genetic heterogeneity, such as Bartter syndrome or steroidresistant nephrotic syndrome [2, 3].”
BackgroundSnoek, R., van Eerde, A. M., & Knoers, N. V. A. M. (2017) · Kidney International · doi:10.1016/j.kint.2017.07.009 · Cited by 8
FAT1 biallelic truncating mutation causes a non-syndromic proteinuria in a child
Rossanti, R., Watanabe, T., Nagano, C., Hara, S., Horinouchi, T., Yamamura, T., Sakakibara, N., Ninchoji, T., Iijima, K., & Nozu, K. (2020) · CEN Case Reports · doi:10.1007/s13730-020-00529-y · Cited by 8
Podocytopathy in Obesity: Challenges of Living Large
Giannini, G., Kopp, J. B., & Rosenberg, A. Z. (2021) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2021.06.003 · Cited by 11
Wang, C., Seltzsam, S., Zheng, B., Wu, C. W., Nicolas, C., Yousef, K., Au, K. S., Mann, N., Pantel, D., Schneider, S., et al. (2022) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62644 · Cited by 8
“…the most common birth defects after congenital heart defects (incidence about 1%; Reller et al., 2008) and besides congenital anomalies of the kidneys and urinary tract (CAKUT; incidence ranging from 0.3 to 1.6 per 1000 births) (Andrés-Jensen et al., 2016; Caiulo et al., 2012; Salih et al., 2014).”
BackgroundInfluentialSelf-citationWilliams, A. E., Esezobor, C. I., Lane, B. M., & Gbadegesin, R. (2022) · Pediatric Nephrology · doi:10.1007/s00467-022-05831-8 · Cited by 10
“For example, the prevalence is the highest in populations where inbreeding is high and in areas where there are founder mutations [29, 49].”
BackgroundA Custom Targeted Next-Generation Sequencing Gene Panel for the Diagnosis of Genetic Nephropathies
Larsen, C. P., Durfee, T., Wilson, J. D., & Beggs, M. L. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.11.023 · Cited by 8
Ali, S. H., Mohammed, R. K., Saheb, H. A., & Abdul–Majeed, B. A. (2017) · International Journal of Nephrology · doi:10.1155/2017/1407506 · Cited by 8
The importance of genetic study in steroid-resistant nephrotic syndrome
Vahed, S. Z., Sani, H. M., Rajabzadeh, S., Nariman‐Saleh‐Fam, Z., Hejazian, S. M., Vahed, F. Z., Khatibi, S. M. H., Shoja, M. M., & Ardalan, M. (2019) · Journal of Renal Injury Prevention · doi:10.15171/jrip.2019.51 · Cited by 9
“Moreover, the association of PLCE1 mutations with congenital NS, DMS, and in the non-negligible proportion of patients with FSGS with no NPHS2 mutation is reported (66-68).”
BackgroundInfluentialIdiopathic Nephrotic Syndrome in Children: Genetic Aspects
Boyer, O., Tory, K., Machuca, E. A., & Antignac, C. (2015) · Springer eBooks · doi:10.1007/978-3-662-43596-0_23 · Cited by 13
“More importantly, NGS approaches have wholly modified the diagnosis screening algorithms, and podocyte gene panels are increasingly used as the first step of genetic analyses in selected patients such as children or adults with familial FSGS [2, 21, 22].”
BackgroundInfluentialKachmar, J., Boyer, O., Lipska-Ziętkiewicz, B. S., Morinière, V., Gribouval, O., Heidet, L., Bałasz–Chmielewska, I., Benetti, E., Cloarec, S., Csaicsich, D., et al. (2024) · Kidney International Reports · doi:10.1016/j.ekir.2024.01.005 · Cited by 7
Li, H. Q., & Li, Y. F. (2025) · Integrative Medicine in Nephrology and Andrology · doi:10.1097/imna-d-24-00035 · Cited by 10
“…root cause of SRNS. [35] Furthermore, comprehensive genetic screening has resulted in the detection of inherited podocytosis in up to 30% of children with SRNS. [37] Minimal change disease (MCD) In most cases, MCD, previously known as lipoid nephropathy, is sensitive to glucocorticoid treatment.”
Clinical features and gene variation analysis of COQ8B nephropathy: Report of seven cases
Liang, R., Chen, X., Zhang, Y., Law, C.-F., Yu, S., Jia, J., Yang, Q., Wu, D., Zhang, G., Chen, H., et al. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2022.1030191 · Cited by 7
Exploring the Multifaceted Role of WT1 in Kidney Development and Disease
Lu, J., Zhang, X., Liu, H., & Liu, Y. (2025) · Kidney & Blood Pressure Research · doi:10.1159/000544025 · Cited by 7
“Among primary nephrotic syndromes, some are ineffective in hormone treatment, that is, steroid-resistant nephrotic syndrome, accounting for approximately 20 – 40% of primary nephrotic syndromes, of which about 29.5% of cases are caused by single-gene mutations [83].”
InfluentialZerkowitz, E., Gellermann, J., Beckus, J., Holle, J. B., Kempf, C., Bufler, P., Müller, D., Thumfart, J., & Klämbt, V. (2025) · Pediatric Nephrology · doi:10.1007/s00467-025-06705-5 · Cited by 7
“Pathogenic disease-causing genetic variants are identified in 29% of SRNS cases [12].”
Battelino, N., Arnol, M., Kandus, A., Ponikvar, R., & Novljan, G. (2016) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.12443 · Cited by 7
“more than 27 genes related to normal podocyte function have been discovered until today (11,12).”
BackgroundNPHS2Mutations: A Closer Look to Latin American Countries
Guaragna, M. S., Lutaif, A. C. G. D. B., Maciel‐Guerra, A. T., Belangero, V. M. S., Guerra‐Júnior, G., & de Mello, M. P. (2017) · BioMed Research International · doi:10.1155/2017/7518789 · Cited by 7
“Nephrotic protein leakage may occur as a result from damage in one of these GFB components [11], although functional pathways specifically in the podocyte have revealed this cell as the key component of the pathogenesis of SRNS [5, 6, 12, 13].”
BackgroundInfluentialLane, B. M., Murray, S. L., Benson, K. A., Bierżyńska, A., Chryst-Stangl, M., Wang, L., Wu, G., Cavalleri, G. L., Doyle, B. J., Fennelly, N. K., et al. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020081234 · Cited by 7
Self-citationPodocyte-specific Transcription Factors: Could MafB Become a Therapeutic Target for Kidney Disease?
Morito, N., Usui, T., Ishibashi, S., & Yamagata, K. (2022) · Internal Medicine · doi:10.2169/internalmedicine.9336-22 · Cited by 9
“WT1 mutations are found in approximately 8%-13% of patients with congenital nephrotic syndrome (52).”
BackgroundLeenen, E., Erger, F., Altmüller, J., Wenzel, A., Thiele, H., Harth, A., Tschernoster, N., Lokhande, S., Joerres, A., Becker, J.-U., et al. (2022) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfac163 · Cited by 8
Fang, Z., Zhang, C., Jin, Y., Tong, J., Liu, J., Xu, H., Weng, Q., Yu, S., Du, W., Cai, Y., et al. (2022) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2022.06.012 · Cited by 7
Loss of surface transport is a main cellular pathomechanism of CRB2 variants causing podocytopathies
Möller‐Kerutt, A., Schönhoff, B., Rellmann, Y., George, B., Braun, D. A., Pavenstädt, H. J., & Weide, T. (2022) · Life Science Alliance · doi:10.26508/lsa.202201649 · Cited by 7
“Remarkably, many proteinuric renal diseases appear in childhood and are monogenetic inherited diseases caused by mutations in podocyte-speci fi c genes (Sadowski et al, 2015; Vivante & Hildebrandt, 2016; Kopp et al, 2020).”
Isaranuwatchai, S., Chanakul, A., Ittiwut, C., Ittiwut, R., Srichomthong, C., Shotelersuk, V., Suphapeetiporn, K., & Praditpornsilpa, K. (2023) · Scientific Reports · doi:10.1038/s41598-022-26291-y · Cited by 7
Genetic diagnosis of kidney disease by whole exome sequencing and its clinical application
Jung, J., Lee, J. H., Seo, G. H., Keum, C., Kang, H. G., Cho, H., Lee, H., Park, S.-K., Baek, C. H., Ro, H., et al. (2023) · Clinical Genetics · doi:10.1111/cge.14382 · Cited by 9
“8%).(7,13,15,28) Autosomal dominant polycystic kidney disease (ADPKD), the most common type of cystic disease/ciliopathy, is primarily diagnosed by direct sequencing.”
BackgroundFSGS Recurrence Collaboration: Report of a Symposium
Gipson, D. S., Wang, C.-S., Salmon, E. C., Gbadegesin, R., Naik, A. S., Sanna‐Cherchi, S., Fornoni, A., Kretzler, M., Merscher, S., Hoover, P., et al. (2023) · Glomerular Diseases · doi:10.1159/000535138 · Cited by 7
“Monogenic causes of FSGS have been reported in up to 30% of individuals presenting with FSGS, with ample variability depending on age of onset of disease and response to treatment [13 – 17].”
BackgroundSiji, A., Pardeshi, V. C., Ravindran, S., Vasudevan, A., & Vasudevan, A. (2017) · BMC Medical Genetics · doi:10.1186/s12881-016-0362-7 · Cited by 7
Prospects for Precision Medicine in Glomerulonephritis Treatment
Liu, Y. C., & Chun, J. (2018) · Canadian Journal of Kidney Health and Disease · doi:10.1177/2054358117753617 · Cited by 9
“Recently, Hildebrandt’s group applied a powerful approach using microfluidic multiplex PCR and NGS to detect a single-gene cause in about 30% of families with steroid-resistant nephrotic syndrome.(90) Using whole-exome sequencing and high-throughput exon sequencing, they were able to identify mutations in 3 nuclear po…”
BackgroundGenetic studies of focal segmental glomerulosclerosis: a waste of scientific time?
Howie, A. J. (2018) · Pediatric Nephrology · doi:10.1007/s00467-018-4161-6 · Cited by 9
Current Therapies in Nephrotic Syndrome: HDAC inhibitors, an Emerging Therapy for Kidney Diseases
Varghese, R. S., & Majumdar, A. S. (2021) · Current Research in Biotechnology · doi:10.1016/j.crbiot.2021.05.007 · Cited by 8
Watanabe, A., Neves, P. D. M. D. M., Nunes, K., Lerário, A. M., Watanabe, E. H., Ferreira, F. M., Malheiros, D. M. A. C., Narcizo, A. D. M., Guaragna, M. S., Araújo, S. D. A., et al. (2024) · Kidney International Reports · doi:10.1016/j.ekir.2024.09.005 · Cited by 6
Self-citationMendelian steroid resistant nephrotic syndrome in childhood: is it as common as reported?
Arslan, Z., Webb, H., Ashton, E., Foxler, B., Tullus, K., Waters, A. M., & Böckenhauer, D. (2022) · Pediatric Nephrology · doi:10.1007/s00467-022-05569-3 · Cited by 6
Rituximab treatment of adults with primary focal segmental glomerulosclerosis
Wang, L., Yu, L., Wang, Y., Guo, Y., Zhai, Z., & Tang, L. (2023) · Scientific Reports · doi:10.1038/s41598-023-33678-y · Cited by 6
Li, S., He, C., Sun, Y., Chen, J., Liu, Y., Huang, Z., Huang, W., Meng, Y., Liu, W., Lei, X., et al. (2024) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-024-01817-4 · Cited by 6
“%) were subjected to WES analysis, and the positive rate of pathogenic gene mutations was 24.7%, which is roughly consistent with other study [30].”
InfluentialHackl, Á., & Weber, L. T. (2025) · Pediatric Nephrology · doi:10.1007/s00467-025-06670-z · Cited by 6
“Finally, myosin 1e may be important for the function of actin cables, as mutations in myosin1e are also associated with FSGS [57, 58].”
GeneVetter: a web tool for quantitative monogenic assessment of rare diseases
Gillies, C. E., Robertson, C. C., Sampson, M. G., & Kang, H. M. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv432 · Cited by 7
PLCε1 suppresses tumor growth by regulating murine T cell mobilization
Strazza, M., Adam, K. R., Smrcka, A. V., Lerrer, S., & Mor, A. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13409 · Cited by 6
The genetics of steroid-resistant nephrotic syndrome in adults
Boyer, O., Dorval, G., & Servais, A. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz257 · Cited by 6
Sinha, R., Sarkar, S., Mandal, K., & Tse, Y. (2020) · Pediatric Transplantation · doi:10.1111/petr.13960 · Cited by 6
Thakor, J. M., Parmar, G., Mistry, K. N., Gang, S. D., RANK, D. N., & Joshi, C. G. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06711-4 · Cited by 6
Predicting and Understanding the Pathology of Single Nucleotide Variants in Human COQ Genes
Wang, S., Jain, A., Novales, N. A., Nashner, A. N., Tran, F., & Clarke, C. F. (2022) · Antioxidants · doi:10.3390/antiox11122308 · Cited by 9
“variant is reported and has been predicted in silico to be deleterious but has not been associated with any clinical manifestations [100].”
BackgroundGenetic analysis and outcomes of Omani children with steroid‐resistant nephrotic syndrome
Riyami, M. S. A., Alawi, I. A., Gaithi, B. A., Maskari, A. A., Kalbani, N. A., Hashmi, N. A., Balushi, A. A., Shahi, M. A., Saidi, S. A., Bimani, M. A., et al. (2023) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.2201 · Cited by 8
Yang, Q., Tang, D., Gan, C., Bai, M., Song, X., Jiang, W., Li, Q., Chen, Y., Zhang, A., & Wang, M. (2023) · Pediatric Nephrology · doi:10.1007/s00467-023-06087-6 · Cited by 6
A case report of CRB2 mutation identified in a Chinese boy with focal segmental glomerulosclerosis
Fan, J., Fu, R., Fuxian, R., He, J., Wang, S., & Gou, M. (2018) · Medicine · doi:10.1097/md.0000000000012362 · Cited by 6
Elshafey, S. A., Thabet, M., Elwafa, R. A., Schneider, R., Shril, S., Buerger, F., Hildebrandt, F., & Fathy, H. (2023) · Acta Paediatrica · doi:10.1111/apa.16732 · Cited by 6
Self-citationGrahammer, F., Benzing, T. R., & Huber, T. B. (2015) · Kidney International · doi:10.1038/ki.2015.5 · Cited by 6
Trachtman, H., Eddy, S. F., & Kretzler, M. (2025) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2025.10.013 · Cited by 6
Efficacy of Calcineurin Inhibition in Children With Steroid-Resistant Nephrotic Syndrome
Trautmann, A., Hofstetter, J., Lipska-Ziętkiewicz, B. S., Tsygin, A. N., Ogarek, I., Saeed, B., Szczepańska, M., Azocar, M. A., Emma, F., Özaltın, F., et al. (2025) · Kidney International Reports · doi:10.1016/j.ekir.2025.07.037 · Cited by 5
Buerger, F., Salmanullah, D., Liang, L., Gauntner, V. C., Krueger, K., Qi, J., Normand, J., Sharma, V., Ranga, A., Rubin, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65663-6 · Cited by 5
“1 – 4), supporting an important role for the, here described, NOS1AP intergenic splice product in kidney disease.”
Self-citationStone, H. K., Parameswaran, S., Eapen, A., Chen, X., Harley, J. B., Devarajan, P., Weirauch, M. T., & Kottyan, L. C. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.09.048 · Cited by 5
“nephrotic syndrome whose disease is caused by structural defects in the glomerular filtration barrier.(4,5) Patients with SSNS likely have more variable phenotypes and a more complex inheritance pattern, making the genetic etiology of this disease more difficult to identify.”
BackgroundHLA Loci and Recurrence of Focal Segmental Glomerulosclerosis in Pediatric Kidney Transplantation
Shaw, B. I., Ochoa, A., Chan, C. C. W., Nobuhara, C. K., Gbadegesin, R., Jackson, A. M., & Chambers, E. T. (2021) · Transplantation Direct · doi:10.1097/txd.0000000000001201 · Cited by 5
Genetic Basis of Nephrotic Syndrome
Gbadegesin, R., Saleem, M. A., Lipska-Ziętkiewicz, B. S., & Boyer, O. (2022) · Springer eBooks · doi:10.1007/978-3-030-52719-8_90 · Cited by 5
Marasà, M., Ahram, D. F., Rehman, A. U., Mitrotti, A., Abhyankar, A., Jain, N. G., Weng, P. L., Piva, S. E., Fernández, H., Uy, N., et al. (2023) · Kidney International Reports · doi:10.1016/j.ekir.2023.05.021 · Cited by 5
“Previous studies have demonstrated a monogenic cause in approximately 20% to 30% of patients with steroid-resistant NS who are below the age of 18 years.(8,9) Genetic forms of NS are usually resistant to immunosuppressive treatment and do not recur following kidney transplantation.”
BackgroundKaur, A., Banday, A. Z., Dawman, L., Rawat, A. K., & Tiewsoh, K. (2023) · Pediatric Nephrology · doi:10.1007/s00467-023-06042-5 · Cited by 5
Saiki, R., Katayama, K., & Dohi, K. (2023) · Biomedicines · doi:10.3390/biomedicines11071803 · Cited by 5
“A previous report suggested that approximately 30% of SRNS cases were caused by a single gene abnormality [2].”
BackgroundPantel, D., Mertens, N. D., Schneider, R., Hölzel, S., Kari, J. A., Desoky, S. M. E., Shalaby, M. A., Lim, T. Y., Sanna‐Cherchi, S., Shril, S., et al. (2023) · Pediatric Nephrology · doi:10.1007/s00467-023-06134-2 · Cited by 6
“With our study, we show that causative CNVs can be detected by genome-wide SNP-based CNV analysis in families with SRNS and that disease-causing CNVs are a much rarer cause of SRNS (1.5% of unsolved SRNS cases) than SNVs (11–30% of SRNS cases) [5, 6, 29].”
InfluentialSelf-citationRoles of myosin 1e and the actin cytoskeleton in kidney functions and familial kidney disease
Liu, P., Sayeeda, K., Zhuang, C., & Krendel, M. (2024) · Cytoskeleton · doi:10.1002/cm.21861 · Cited by 6
“On the other hand, the autosomal dominant type of SRNS results in later-onset proteinuria, including the adult-onset disease that occurs after the age of 18, with mutations in genes such as TRPC6 , ACTN4 , and (Hildebrandt & Heeringa, 2009; Sadowski et al., 2015).”
Riguetti, M. T. P., Varela, P., Fernandes, D. E., Polito, M. G., da Fonseca, F. M. C., Pesquero, J. B., & Kirsztajn, G. M. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.533373 · Cited by 5
Miura, K., Ando, T., Kanda, S., Hashimoto, T., Kaneko, N., Ishizuka, K., Hamada, R., Hataya, H., Hotta, K., Gotoh, Y., et al. (2021) · Pediatric Transplantation · doi:10.1111/petr.14103 · Cited by 5
Liu, Z., Zhang, H., Zhao, S., Zhang, Q., Zhang, R., Han, Y., Shao, L., & Zhao, X. (2021) · Nephrology · doi:10.1111/nep.13963 · Cited by 5
“About 27 causal genes have been identified responsible for recessive or dominant forms of FSGS by now.(4) These causative genes encode proteins confined to podocyte and involved in a broad spectrum of podocyte functions.”
BackgroundAcharya, R., & Upadhyay, K. K. (2021) · Clinical Case Reports · doi:10.1002/ccr3.5111 · Cited by 5
Isolated benign persistent proteinuria with novel association of CUBN (cubilin) variants
Shi, V., Stein, Q., Clark, D. M., Punj, S., Kremsdorf, R. A., & Faizan, M. K. (2023) · Clinical Case Reports · doi:10.1002/ccr3.7502 · Cited by 5
Genetic mutational testing of Chinese children with familial hematuria with biopsy‑proven FSGS
Li, Y., Wang, Y. X., He, Q., Dang, X., Cao, Y. H., Wu, X., Mo, S.-H., He, X., & Yi, Z.-W. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8023 · Cited by 5
“The introduction of more comprehensive screening technologies including WES allows simultaneous screens for mutations in other potentially relevant genes and contributes to the detection of novel genes or mutations (48,49), instead of testing for one gene at a time, or screening for certain known mutations only.”
BackgroundSteroid-resistant nephrotic syndrome caused by novel WT1 mutation inherited from a mosaic parent
Beltcheva, O., Boueva, A., Tzveova, R., Roussinov, D., Marinova, S., Kaneva, R. P., & Mitev, V. (2015) · Renal Failure · doi:10.3109/0886022x.2015.1117906 · Cited by 5
Tavakolidakhrabadi, N., Ding, W. Y., Welsh, G. I., & Saleem, M. A. (2025) · Clinical Kidney Journal · doi:10.1093/ckj/sfaf332 · Cited by 4
“Monogenic FSGS has been reported in 21.4% of patients with onset of disease between 19 and 25 years of age [81 ].”
InfluentialHe, Z., Wu, K., Xie, W., & Chen, J. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.930258 · Cited by 5
“Actinin alpha 4 has three main domains: (1) the N-terminal highly conserved ABD consists of two calponin homology (CH1/2); (2) spectrin 1-4; and (3) the C-terminal domain consists of EF-hand 1/2 (Figure 4).”
BackgroundCheng, X., Chen, J., Yang, X., Chan, H., Yang, X., Jia, J., Wang, A., Zhang, G., Chen, X., Li, X., et al. (2024) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-024-01655-4 · Cited by 4
“The highest proportion of 62.5% was found in those 0–3 months old, which is almost equal to the 69.4% reported in other studies that included children with single gene-positive NS in 526 families [25].”
ResultInfluentialNephrotic Syndrome Throughout Childhood: Diagnosing Podocytopathies From the Womb to the Dorm
Finn, L. S. (2024) · Pediatric and Developmental Pathology · doi:10.1177/10935266241242669 · Cited by 4
“10 The clinical and histopathologic spectrum associated with PLCE1 has expanded since the original discovery, and several larger studies have found disease causing mutations in familial and sporadic SRNS.”
InfluentialGenotype–phenotype correlations and clinical outcomes of genetic TRPC6 podocytopathies
McAnallen, S. M., Elhassan, E. A. E., Stoneman, S., Vairo, F. P. E., Hogan, M. C., Hoefele, J., Clince, M., Mekraksakit, P., Titan, S., Jorge, S. C., et al. (2025) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaf086 · Cited by 5
Fifty Shades of Risk: Population Studies and the Genetic Architecture of Kidney Diseases
Sadeghi‐Alavijeh, O., Chan, M., Stanescu, H. C., Gale, D. P., & Böckenhauer, D. (2025) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000893 · Cited by 5
A descriptive study of NPHS1 and NPHS2 mutations in children with congenital nephrotic syndrome
Amr, K. S., El-Bassyouni, H. T., Rabie, E., Selim, A., Zaki, M. E., Alazem, E. A. A., Elshaer, S. S., Rady, S., & Salah, D. M. (2020) · Gene Reports · doi:10.1016/j.genrep.2020.100722 · Cited by 4
Phenotype, genotype, and clinical outcome of Taiwanese with congenital nephrotic syndrome
Tseng, M., Lin, S., Fan, W., Wu, T., Lin, S., Ding, J.-J., Tsai, I., & Tsai, J.-D. (2023) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2023.10.003 · Cited by 4
Metadata
- Authors
- Sadowski, C. E., Lovric, S., Ashraf, S., Pabst, W. L., Gee, H. Y., Kohl, S., Engelmann, S., Vega-Warner, V., Fang, H., Halbritter, J., Somers, M. J., Tan, W., Shril, S., Fessi, I., Lifton, R. P., Bockenhauer, D., El-Desoky, S., Kari, J. A., Zenker, M., Kemper, M. J., Mueller, D., Fathy, H. M., Soliman, N. A., & Hildebrandt, F.
- Affiliations
- Boston Children's Hospital (US)
- University of Michigan (US)
- Howard Hughes Medical Institute (US)
- King Abdul Aziz University Hospital (SA)
- Otto-von-Guericke-Universität Magdeburg (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Stiftung Charité (DE)
- Alexandria University (EG)
- Cairo University (EG)
- Corresponding author
- Sadowski, Carolin E.
- Lovric, Svjetlana
- Ashraf, Shazia
- Pabst, Werner L.
- Gee, Heon Yung
- Kohl, Stefan
- Engelmann, Susanne
- Fang, Humphrey
- Halbritter, Jan
- Somers, Michael J.
- Tan, Weizhen
- Shril, Shirlee
- Fessi, Inès
- Kemper, Markus J.
- Hildebrandt, Friedhelm
- ORCID
- Venue
- Journal of the American Society of Nephrology
- Published
- 2015-06
- Volume
- 26
- Issue
- 6
- Pages
- 1279-1289
- ISSN
- 1046-6673 (ISSN-L)
- PMC
- PMC4446877
- OpenAlex
- W2163605874
- Cited by
- 651
- References
- 41
- Citations by year
- 2026: 45 · 2025: 40 · 2024: 45 · 2023: 63 · 2022: 69 · 2021: 61 · 2020: 55 · 2019: 55 · 2018: 64 · 2017: 62 · 2016: 50 · 2015: 40
- FWCI
- 40.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Scholarship@Western (Western University) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Nephcure Foundation
- Kidney Research UK (RP45/2008)
- National Institutes of Health
- Manton Center for Orphan Disease Research, Boston Children's Hospital
- National Institute of Diabetes and Digestive and Kidney Diseases (RC4-DK076683, P30DK079310, R01DK076683)
- Topics
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Health Sciences › Medicine › Oncology › Renal and related cancers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- steroid-resistant nephrotic syndrome, NPHS2, WT1, PLCE1, coenzyme Q10 biosynthesis, age of onset, genotype-phenotype correlation, molecular genetic diagnosis, pediatric kidney disease, end-stage renal disease
- MeSH terms
- Adolescent, Adult, Child, Child, Preschool, Female, Genotype, Heterozygote, Humans, Infant, Male, Membrane Proteins, Middle Aged, Mutation, Nephrotic Syndrome, Pedigree, Phenotype, Retrospective Studies, Cohort Studies, Incidence, Genes, Wilms Tumor, Age of Onset, Risk Assessment, Genetic Predisposition to Disease, Intracellular Signaling Peptides and Proteins, Young Adult, Genetic Association Studies, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.